NovoCure Ltd (NVCR)
17.09
+0.23
(+1.36%)
USD |
NASDAQ |
Nov 21, 16:00
17.11
+0.02
(+0.12%)
After-Hours: 20:00
NovoCure Enterprise Value: 1.544B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.544B |
| November 20, 2024 | 1.519B |
| November 19, 2024 | 1.478B |
| November 18, 2024 | 1.397B |
| November 15, 2024 | 1.438B |
| November 14, 2024 | 1.487B |
| November 13, 2024 | 1.630B |
| November 12, 2024 | 1.623B |
| November 11, 2024 | 1.663B |
| November 08, 2024 | 1.582B |
| November 07, 2024 | 1.604B |
| November 06, 2024 | 1.653B |
| November 05, 2024 | 1.493B |
| November 04, 2024 | 1.490B |
| November 01, 2024 | 1.445B |
| October 31, 2024 | 1.337B |
| October 30, 2024 | 1.533B |
| October 29, 2024 | 1.522B |
| October 28, 2024 | 1.493B |
| October 25, 2024 | 1.506B |
| October 24, 2024 | 1.464B |
| October 23, 2024 | 1.444B |
| October 22, 2024 | 1.440B |
| October 21, 2024 | 1.453B |
| October 18, 2024 | 1.555B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.521B |
| October 16, 2024 | 1.626B |
| October 15, 2024 | 1.617B |
| October 14, 2024 | 1.431B |
| October 11, 2024 | 1.397B |
| October 10, 2024 | 1.302B |
| October 09, 2024 | 1.279B |
| October 08, 2024 | 1.279B |
| October 07, 2024 | 1.274B |
| October 04, 2024 | 1.286B |
| October 03, 2024 | 1.266B |
| October 02, 2024 | 1.370B |
| October 01, 2024 | 1.304B |
| September 30, 2024 | 1.384B |
| September 27, 2024 | 1.392B |
| September 26, 2024 | 1.396B |
| September 25, 2024 | 1.428B |
| September 24, 2024 | 1.480B |
| September 23, 2024 | 1.491B |
| September 20, 2024 | 1.591B |
| September 19, 2024 | 1.633B |
| September 18, 2024 | 1.608B |
| September 17, 2024 | 1.652B |
| September 16, 2024 | 1.646B |
| September 13, 2024 | 1.712B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
836.10M
Minimum
Nov 10 2023
23.02B
Maximum
Jun 23 2021
7.658B
Average
7.349B
Median
Jul 06 2022
Enterprise Value Benchmarks
| Abbott Laboratories | 210.81B |
| Perspective Therapeutics Inc | -63.40M |
| Retractable Technologies Inc | -17.27M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -30.57M |
| Revenue (Quarterly) | 155.10M |
| Total Expenses (Quarterly) | 187.19M |
| EPS Diluted (Quarterly) | -0.28 |
| Gross Profit Margin (Quarterly) | 77.19% |
| Profit Margin (Quarterly) | -19.71% |
| Earnings Yield | -8.19% |
| Normalized Earnings Yield | -8.192 |